Advertisement
Advertisement
U.S. markets open in 1 hour 1 minute
Advertisement
Advertisement
Advertisement
Advertisement

BCII Enterprises Inc. (BCII)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.1205+0.0055 (+4.78%)
At close: 03:48PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close0.1150
Open0.1175
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range0.1150 - 0.1260
52 Week Range0.1000 - 0.5410
Volume8,015
Avg. Volume11,573
Market Cap17.1M
Beta (5Y Monthly)77.78
PE Ratio (TTM)N/A
EPS (TTM)-0.1170
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
N/A

Subscribe to Yahoo Finance Plus to view Fair Value for BCII

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • BCII ENTERPRISES INC
    ARWR: Lowering target price to $35.00ARROWHEAD PHARMACEUTICALS IN has an Investment Rating of HOLD; a target price of $35.000000; an Industry Subrating of High; a Management Subrating of Low; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
    Rating
    Fair Value
    Economic Moat
    5 days agoArgus Research
View more
Advertisement
Advertisement